.png){kind=icon}
返回
Modulating the complement system through epitope-specific inhibition by complement C3 inhibitors
.png){kind=icon}
OA
AI
DOI：10.1016/j.jbc.2025.108250.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
As an integral part of the innate immune system, the complement system is a tightly regulated proteolytic cascade, playing a critical role in microbial defense, inflammation activation, and dying host cell clearance. Complement proteins are now emerging as subjects of intense research and drug development, since dysregulation of the complement system plays a critical role in several diseases and disorders, such as paroxysmal nocturnal hemoglobinuria (PNH) and geographic atrophy (GA). Within the complement cascade, complement C3 is the central component, situated at the convergence of all complement activation pathways, rendering it an attractive target for complement-related diseases. However, due to the complicated structure-activity relationship (SAR) of C3, elucidating the mechanisms of C3 inhibition on diverse epitopes is the basis for the rational design of C3-targeted therapeutics. Here, we have developed a set of comprehensive biochemical assays that are tailored to the specific steps within the complement cascade, allowing for a thorough understanding of the pharmacological consequences of different C3 inhibitors at each stage. Utilizing three model inhibitors (MIs) with different epitopes, we found that inhibition of MG4/MG5 domains has potent inhibition efficacy across all the complement activation pathways by interrupting C3-C3 convertase interaction, while inhibition of C345C domain displays a bias over the Alternative pathway (AP) inhibition by impairing AP C3 proconvertase formation. This study elucidates the intricate impact of C3 inhibition by targeting different epitopes, offering valuable insights into understanding the mechanism and facilitating the rational design of C3-targeted therapeutics.
Keyword:
C3-SPECIFIC NANOBODY
PATHWAY
ECULIZUMAB
ACTIVATION
MECHANISM
DISEASE
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
3.9
论文数:
11.2W
被引数:
28.3W
机构
引用论文
A comparison study of the two-tier and the single-tier personal communications services systems
PREAI
分享收藏Structure of complement fragment C3b-factor H and implications for host protection by complement regulators.png)
NATURE IMMUNOLOGYOAAI
NATURE IMMUNOLOGYIF27.6
OAAI分享收藏Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction非均匀细化: 自适应正则化改进单粒子cryo-em重建NATURE METHODSOAAI
NATURE METHODSIF32.1
OAAI分享收藏Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapy靶向C3b/C4b和VEGF的双特异性融合蛋白优化用于新生血管性年龄相关性黄斑变性治疗
PREAI
分享收藏UCSF chimera - A visualization system for exploratory research and analysisUCSF chimera-用于探索性研究和分析的可视化系统OAAI
OAAI分享收藏The Liquid–Liquid Dispersion Homogeneity in a Vessel Agitated by a High-Shear Sawtooth ImpellerProcessesOAAI
ProcessesIF0
OAAI分享收藏
查看更多内容